Canada reassessment of avermectin and its end-use products
On February 28, 2023, Health Canada released consultation document PRVD2023-01, in which the Pest Management Authority (PMRA) reevaluated Abamectin and its end-use products, proposing to eliminate the use of abamectin in greenhouse ornamental flowers.
It is understood that abamectin is an acaricide/insecticide registered for use in a wide range of outdoor field-grown fruit and vegetable crops, outdoor ornamentals, greenhouse vegetables and greenhouse ornamentals to control or suppress a variety of agricultural pests such as mites, leaf bees, moths, thrips, pied burners, psyllids, aphids and certain beetles. It is also registered for use in commercial and domestic indoor and/or outdoor buildings to control cockroaches and ants.
The registration is open for public comment from February 28, 2023 to May 29, 2023.
2026-10-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Limin Shares to build a synthetic biology laboratory, focusing on the layout of 'biosynthesis' products
-
Notice: The wheat spiders are about to appear in large numbers
-
Cyhalothrin was expanded to bitter gourd in China
-
Veyong, a subsidiary of Limin, was shortlisted for two honor lists successively
-
Vertex Buys Crinetics for $10 Billion: Rare Disease M&A Is Back
-
Nestlé Drops Artificial Colors Worldwide by 2026: Food Additives Face a Reformulation Shock
-
Trump Tariff "Boomerang": $2.5 Billion Polysilicon Factory Faces Shutdown Crisis
-
U.S. Includes Lithium in National Defense Stockpile for First Time, Plans to Purchase 16,200 Tons Over Five Years
-
Selling the Family Silver for a New Suit? Why Bohai Chemical’s Transformation Drama Got Canceled After Just Two Acts
-
U.S. Issues Final Anti-Dumping Ruling on Chinese MDI: Dumping Margins Reduced from Over 500% to 85%+
Recommend Reading
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
U.S. Health Chief Says No Evidence Linking Tylenol to Autism
-
From Painting Walls to Total Collapse: The RMB 152 Million Debt That Tore Off the Last Veil of Asia Chuangneng’s Paint Empire
-
India Strengthens Drug Approval Oversight with Expanded CDSCO Powers
-
Strides Pharma Reports Strong Q2 as Net Profit Surges 82%
-
Business Society’s Market Outlook for Acrylic Acid on September 7, 2026: Strong Consolidation
-
Business Society’s Market Outlook for Isooctanol on September 7, 2026: More Warnings of Resistance to Decline
-
Business Society’s Market Outlook for Epichlorohydrin on September 7, 2026: Fluctuating (Bullish) Trend
-
Business Society’s Market Outlook for Phthalic Anhydride on September 7, 2026: Relatively Resilient with a Bias Toward Stability
-
Business Society’s Market Outlook for Toluene on September 7, 2026: Volatile but Relatively Strong